Lipoprotein apheresis efficacy and challenges: single center experience [PDF]
Hematology, Transfusion and Cell Therapy, 2022 Introduction: Lipoprotein apheresis (LA) is an extracorporeal therapy which removes apolipoprotein B-containing particles from the circulation. We evaluated techniques and efficiency of lipoprotein apheresis procedures applied to patients with familial ...
Zehra Narlı Özdemir +4 more
doaj +2 more sources
Changing from lipoprotein apheresis to evolocumab treatment lowers circulating levels of arachidonic acid and oxylipins [PDF]
Atherosclerosis PlusBackground and aims: Previous studies have shown that lipoprotein apheresis can modify the plasma lipidome and pro-inflammatory and pro-thrombotic lipid mediators.
Chaoxuan Wang +12 more
doaj +2 more sources
Case report: lipoprotein apheresis reduces the risk of cardiovascular events and prolongs pregnancy in a woman with severely elevated lipoprotein(a), cardiovascular disease, and a high risk of preeclampsia [PDF]
Frontiers in Medicine, 2023 BackgroundPreeclampsia is a common and serious pregnancy-induced disease, with potential severe maternal and fetal complications. Recently, an increased lipoprotein (a) (Lp[a]) concentration, an important factor in cardiovascular diseases (CVDs ...
Joanna Marlȩga-Linert +5 more
doaj +2 more sources
Beyond lipids: Systemic effects of lipoprotein apheresis. [PDF]
TransfusionTransfusion, Volume 66, Issue 3, Page 590-598, March 2026.
Nadim M, Akgun Y.
europepmc +2 more sources
Oxidised LDL and Anti-Oxidised LDL Antibodies Are Reduced by Lipoprotein Apheresis in a Randomised Controlled Trial on Patients with Refractory Angina and Elevated Lipoprotein(a) [PDF]
Antioxidants, 2021 Aims: An abundance of epidemiological evidence demonstrates that elevated lipoprotein(a) (Lp(a)) represents a significant contributing risk factor towards the development of cardiovascular disease.
Tina Z. Khan +7 more
doaj +2 more sources
Lipoprotein apheresis to treat elevated lipoprotein (a)1 [PDF]
Journal of Lipid Research, 2016 An elevated plasma concentration of lipoprotein (a) [Lp(a)] is an independent risk factor for cardiovascular disease. Life style modification and currently available drugs either fail to effectively lower plasma Lp(a) levels or do not result in clinical ...
Elisa Waldmann, Klaus G. Parhofer
doaj +2 more sources
Monitoring of up to 15 years effects of lipoprotein apheresis on lipids, biomarkers of inflammation, and soluble endoglin in familial hypercholesterolemia patients [PDF]
Orphanet Journal of Rare Diseases, 2021 Background Lipoprotein apheresis (LA) is considered as an add-on therapy for patients with familial hypercholesterolemia (FH). We aimed to analyze the data collected in the last 15 years from FH patients treated with LA, to elucidate the benefit of this ...
J. Víšek +11 more
doaj +2 more sources
Asian Journal of Transfusion Science, 2021 Familial hypercholesterolemia (FH) is characterized by an increase in plasma low-density lipoprotein-cholesterol (LDL-C) levels. It presents with tendon/skin xanthomas and premature atherosclerotic cardiovascular disease.
Daljit Kaur +7 more
doaj +2 more sources
Lipoprotein apheresis affects the concentration of extracellular vesicles in patients with elevated lipoprotein (a) [PDF]
Scientific ReportsLipoprotein apheresis (LA) is a therapeutic option for hyperlipoproteinemia(a) (hyper-Lp(a)) and atherosclerotic cardiovascular disease (ASCVD). LA improves blood rheology, reduces oxidative stress parameters and improves endothelial function.
Joanna Marlęga-Linert +8 more
doaj +2 more sources
Current Role of Lipoprotein Apheresis. [PDF]
Curr Atheroscler Rep, 2019 Thompson G, Parhofer KG.
europepmc +2 more sources